<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xml:base="https://www.tellmeproject.eu/taxonomy/term/87/all" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:fb="http://www.facebook.com/2008/fbml" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:og="http://ogp.me/ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:sioc="http://rdfs.org/sioc/ns#" xmlns:sioct="http://rdfs.org/sioc/types#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#">
  <channel>
    <title>H5N1</title>
    <link>https://www.tellmeproject.eu/taxonomy/term/87/all</link>
    <description></description>
    <language>en</language>
     <atom:link href="https://www.tellmeproject.eu/taxonomy/term/87/all/feed" rel="self" type="application/rss+xml" />
      <item>
    <title>Bird flu vaccine with adjuvant approved by FDA</title>
    <link>https://www.tellmeproject.eu/content/bird-flu-vaccine-adjuvant-approved-fda</link>
    <description>&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; property=&quot;content:encoded&quot;&gt;&lt;p&gt;An adjuvanted vaccine against influenza A (H5N1) virus has been approved by the US Food and Drug Administration (FDA). The vaccine, Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, also referred to as Q-Pan H5N1, has been tested for safety by comparing approximately 3,400 adults 18 years of age and older who received the vaccine to about 1,100 adults who received placebo. This product was produced by a Canadian subsidiary of GlaxoSmithKline Biologicals and is intended for use in people 18 years of age and older who are at increased risk of exposure to the H5N1 influenza virus.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-tags field-type-taxonomy-term-reference field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Tags:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/vaccine&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Vaccine&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/h5n1&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;H5N1&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/avianbird-flu&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Avian/Bird Flu&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description>
     <pubDate>Tue, 26 Nov 2013 19:57:13 +0000</pubDate>
 <dc:creator>amministratore</dc:creator>
 <guid isPermaLink="false">230 at https://www.tellmeproject.eu</guid>
  </item>
  <item>
    <title>Bird flu vaccine with adjuvant approved by FDA</title>
    <link>https://www.tellmeproject.eu/content/bird-flu-vaccine-adjuvant-approved-fda</link>
    <description>&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; property=&quot;content:encoded&quot;&gt;&lt;p&gt;An adjuvanted vaccine against influenza A (H5N1) virus has been approved by the US Food and Drug Administration (FDA). The vaccine, Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, also referred to as Q-Pan H5N1, has been tested for safety by comparing approximately 3,400 adults 18 years of age and older who received the vaccine to about 1,100 adults who received placebo. This product was produced by a Canadian subsidiary of GlaxoSmithKline Biologicals and is intended for use in people 18 years of age and older who are at increased risk of exposure to the H5N1 influenza virus.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-tags field-type-taxonomy-term-reference field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Tags:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/vaccine&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Vaccine&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/h5n1&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;H5N1&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/avianbird-flu&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Avian/Bird Flu&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description>
     <pubDate>Tue, 26 Nov 2013 19:57:13 +0000</pubDate>
 <dc:creator>amministratore</dc:creator>
 <guid isPermaLink="false">230 at https://www.tellmeproject.eu</guid>
  </item>
  <item>
    <title>Bird flu vaccine with adjuvant approved by FDA</title>
    <link>https://www.tellmeproject.eu/content/bird-flu-vaccine-adjuvant-approved-fda</link>
    <description>&lt;div class=&quot;field field-name-body field-type-text-with-summary field-label-hidden&quot;&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; property=&quot;content:encoded&quot;&gt;&lt;p&gt;An adjuvanted vaccine against influenza A (H5N1) virus has been approved by the US Food and Drug Administration (FDA). The vaccine, Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, also referred to as Q-Pan H5N1, has been tested for safety by comparing approximately 3,400 adults 18 years of age and older who received the vaccine to about 1,100 adults who received placebo. This product was produced by a Canadian subsidiary of GlaxoSmithKline Biologicals and is intended for use in people 18 years of age and older who are at increased risk of exposure to the H5N1 influenza virus.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class=&quot;field field-name-field-tags field-type-taxonomy-term-reference field-label-above&quot;&gt;&lt;div class=&quot;field-label&quot;&gt;Tags:&amp;nbsp;&lt;/div&gt;&lt;div class=&quot;field-items&quot;&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/vaccine&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Vaccine&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item odd&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/h5n1&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;H5N1&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;field-item even&quot; rel=&quot;dc:subject&quot;&gt;&lt;a href=&quot;/tags/avianbird-flu&quot; typeof=&quot;skos:Concept&quot; property=&quot;rdfs:label skos:prefLabel&quot; datatype=&quot;&quot;&gt;Avian/Bird Flu&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description>
     <pubDate>Tue, 26 Nov 2013 19:57:13 +0000</pubDate>
 <dc:creator>amministratore</dc:creator>
 <guid isPermaLink="false">230 at https://www.tellmeproject.eu</guid>
  </item>
  </channel>
</rss>
